Natural killer cell cytolytic function in Korean patients with adult-onset still's disease

Journal of Rheumatology

Volumn 39, Issue 10, 2012, Pages 2000-2007

  Park, Jeong H A ^a   Kim, Hee Sun ^b   Lee, Jin Sook ^c   Kim, Jin J ^d   Jung, Kyong Hee ^e   Park, Yong Wook ^f   Yoo, Dae Hyun ^c,g  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

^d Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^e Inha University Hospital   (South Korea)

^f Chonnam National University Medical School   (South Korea)

^g Hospital for Rheumatic Diseases   (South Korea)

Author keywords

Adult onset still's disease; Interleukin 18; Interleukin 18 binding protein; Macrophage activation syndrome; Natural killer cell

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; GRANZYME B; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; METHOTREXATE; PERFORIN;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; BONE MARROW BIOPSY; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLYSIS; CYTOPENIA; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FLOW CYTOMETRY; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; INTERLEUKIN-18; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; REPUBLIC OF KOREA; STILL'S DISEASE, ADULT-ONSET;

EID: 84867051755     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111500     Document Type: Article

References (29)

1. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities? Curr Opin Rheumatol 2003;15:587-90. (Pubitemid 37041397)
2. Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: A report of six patients and a review of the literature. Ann Rheum Dis 2006;65:1596-601. (Pubitemid 44799671)
3. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633-9. (Pubitemid 37296468)
4. Sullivan KE, Delaat CA, Douglas SD, Filipovich AH. Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 1998;44:465-8. (Pubitemid 28447329)
5. Egeler RM, Shapiro R, Loechelt B, Filipovich A. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18:340-5. (Pubitemid 26359249)
6. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60. (Pubitemid 32234613)
7. Chen DY, Lan JL, Lin FJ, Hsieh TY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004;31:2189-98.
8. Maruyama J, Inokuma S. Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases. J Rheumatol 2010;37:967-73.
9. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 2005;7:R30-7.
10. Grom AA. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004;50:689-98. (Pubitemid 38326166)
11. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
12. Fujii T, Nojima T, Yasuoka H, Satoh S, Nakamura K, Kuwana M, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology 2001;40:1398-404.
13. Nair MP, Schwartz SA. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes. J Immunol 1984;132:2876-82. (Pubitemid 14105670)
14. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61-6.
15. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: A novel modulator of the Th1 cytokine response. Immunity 1999;10:127-36. (Pubitemid 29077390)
16. Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334-42. (Pubitemid 32730474)
17. Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci USA 2000;97:1190-5. (Pubitemid 30080834)
18. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6. (Pubitemid 36338013)
19. Papo T, Andre MH, Amoura Z, Lortholary O, Tribout B, Guillevin L, et al. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. J Rheumatol 1999;26:927-30. (Pubitemid 29195685)
20. Baxter AG, Smyth MJ. The role of NK cells in autoimmune disease. Autoimmunity 2002;35:1-14. (Pubitemid 34678715)
21. Deane S, Selmi C, Teuber SS, Gershwin ME. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol 2010;153:109-20.
22. Arlet JB, Le Thi Huong DB, Pouchot J, Piette JC. [Current concepts on the physiopathology of adult-onset Still's disease]. Rev Med Interne 2005;26:549-56.
23. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology 2003;42:375-9. (Pubitemid 36312936)
24. Takada H, Nomura A, Ohga S, Hara T. Interleukin-18 in hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2001;42:21-8. (Pubitemid 32700919)
25. Wouters CH, Ceuppens JL, Stevens EA. Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clin Exp Rheumatol 2002;20:239-48. (Pubitemid 34413708)
26. Scheinberg MA, Chapira E, Fernandes ML, Hubscher O. Interleukin 6: A possible marker of disease activity in adult onset Still's disease. Clin Exp Rheumatol 1996;14:653-5. (Pubitemid 27013353)
27. Sugiura T, Kawaguchi Y, Harigai M, Terajima-Ichida H, Kitamura Y, Furuya T, et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002;3:394-9. (Pubitemid 41656537)
28. Choi JH, Suh CH, Lee YM, Suh YJ, Lee SK, Kim SS, et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7. (Pubitemid 37413904)
29. Banda NK, Vondracek A, Kraus D, Dinarello CA, Kim SH, Bendele A, et al. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol 2003;170:2100-5. (Pubitemid 36197432)